1 – 10 of 47
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Identification of an osteopontin-derived peptide that binds neuropilin-1 and activates vascular repair responses and angiogenesis
(
- Contribution to journal › Article
- 2023
-
Mark
Ablation of GPR56 Causes β-Cell Dysfunction by ATP Loss through Mistargeting of Mitochondrial VDAC1 to the Plasma Membrane
(
- Contribution to journal › Article
-
Mark
Transforming growth factor-β2 is associated with atherosclerotic plaque stability and lower risk for cardiovascular events
(
- Contribution to journal › Article
- 2021
-
Mark
Antibodies against apoB100 peptide 210 inhibit atherosclerosis in apoE-/- mice
(
- Contribution to journal › Article
- 2020
-
Mark
The proteoglycan mimecan is associated with carotid plaque vulnerability and increased risk of future cardiovascular death
(
- Contribution to journal › Article
-
Mark
Syndecan-4 Protects the Heart From the Profibrotic Effects of Thrombin-Cleaved Osteopontin
(
- Contribution to journal › Article
-
Mark
An osteopontin-derived peptide inhibits human hair growth at least in part by decreasing fibroblast growth factor-7 production in outer root sheath keratinocytes
(
- Contribution to journal › Article
-
Mark
Inhibitory effect of UDP-glucose on cAMP generation and insulin secretion
(
- Contribution to journal › Article
-
Mark
Orphan G-protein coupled receptor 183 (GPR183) potentiates insulin secretion and prevents glucotoxicity-induced β-cell dysfunction
(
- Contribution to journal › Article
- 2019
-
Mark
Activation of immune responses against the basement membrane component collagen type IV does not affect the development of atherosclerosis in ApoE-deficient mice
(
- Contribution to journal › Article